Kolexia
Paul Carle Dermatologie
Paul Carle
Dermatologie
Hôpital Larrey Toulouse
Toulouse, France
750 Activités
2.1 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Psoriasis Eczéma atopique Dermatite Mastocytose Maladies de la peau Prurit Mastocytose généralisée Mélanome Tumeurs cutanées

Collaborateurs

Voir plus
Livideanu Cristina
Livideanu Cristina
Hôpital Larrey Toulouse, Toulouse, France
Richard Marie Aleth
Richard Marie Aleth
Hôpital La Timone, Marseille, France
Jullien Denis
Jullien Denis
Hôpital Edouard Herriot, Lyon, France
Joly Pascal
Joly Pascal
Hôpital Charles Nicolle, Rouen, France

Industries

Voir plus
Janssen
58 collaboration(s)
Dernière en 2023
Abbvie
25 collaboration(s)
Dernière en 2023
Lilly
22 collaboration(s)
Dernière en 2023
UCB
9 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
Human neutrophils drive skin autoinflammation by releasing interleukin (IL)-26.
The Journal of experimental medicine   06 mars 2024
The prevalence of osteoporosis is low in adult cutaneous mastocytosis patients.
The journal of allergy and clinical immunology. In practice   27 février 2024
Changing the lives of patients with skin diseases-The JEADV's motto.
Journal of the European Academy of Dermatology and Venereology : JEADV   26 février 2024
Correction: Landscape of mast cell populations across organs in mice and humans.
The Journal of experimental medicine   24 janvier 2024
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
American journal of clinical dermatology   23 janvier 2024
Deucravacitinib in plaque psoriasis: 2-year safety and efficacy results from the phase 3 poetyk trials.
The British journal of dermatology   16 janvier 2024
IL-4Rα Inhibition for Severe "Eosinophilic Gastroenteritis, Allergy, and Anaphylaxis" Syndrome due to a Gain-of-Function Variant in STAT6.
Journal of clinical immunology   22 décembre 2023
ALLEGRO-LT: A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY AND EFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA
Essai Clinique (Pfizer)   21 décembre 2023
Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO).
Dermatology and therapy   19 décembre 2023
Price variability of TNF-α inhibitor biosimilars among European countries.
Journal of the European Academy of Dermatology and Venereology : JEADV   18 décembre 2023